Presenting the webinar will be Eric S. Kastango, MBA, BSPharm, FASHP, is president of Clinical IQ LLC, a health care consulting firm and CriticalPoint, LLC, a web-based education company
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, is hosting a complimentary webinar with Eric S. Kastango, MBA., BSPharm, FASHP in "Compounding Quality Act, Title I of the Drug Quality and Security Act of 2013: Understanding its compounding and outsourcing."
On November 27, 2013, President Obama signed the Drug Quality and Security Act (DQSA), legislation that contains important provisions relating to the oversight of compounding of human drugs. Kastango will review the elements of the changes made to Section 503A of the Federal Food, Drug and Cosmetic Act and created a new section, 503B that deals with outsourcing facilities. This new law will be important to learn about how FDA is planning to oversee the outsourcing industry.
Compounding Quality Act, Title I of the Drug Quality and Security Act of 2013: Understanding its Compounding and Outsourcing
Date: Wednesday, April 2, 2014
Time: 1:00 PM - 2:00 PM ET
About the Presenter
Eric S. Kastango, MBA, BSPharm, FASHP, is president of Clinical IQ LLC, a health care consulting firm and CriticalPoint, LLC, a web-based education company.
Mr. Kastango received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Master of Business Administration degree from the University of Phoenix.
Since 1980, he has practiced pharmacy in a number of practice settings, including hospitals, community, and home care, in a number of different of roles, including the Corporate Vice President of Pharmacy Services for Coram Healthcare Corporation. He has also managed a FDA-registered cGMP manufacturing operation for Baxter Healthcare Corporation.
He is an active member and Fellow of the American Society of Healthcare Pharmacists and served on the USP Sterile Compounding Committee from 2005-2010 and was recently re-elected to the 2010-2015 USP Council of Experts, Compounding Expert Committee and served until April 2013. He is currently an Expert Consultant to the USP. Eric has over 150 invited national and international professional presentations on various pharmacy practice topics such as pharmacy compounding and quality systems.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health's customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language ®, Lexicomp ®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid ®, Pharmacy OneSource®, ProVation ® Medical and UpToDate ®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.